Dorzolamide Maleic Acid Adduct
Dorzolamide Maleic Acid Adduct is an impurity of Ophthalmic dorzolamide which is utilised to treat glaucoma, a condition in which increased pressure in the eye can lead to gradual loss of vision. It belongs to a class of medications called carbonic anhydrase inhibitors. It acts by decreasing the pressure in the eye
Additional information on Dorzolamide Maleic Acid Adduct
Catalogue No.
VE008783
CAS No.
N/A
Molecular Formula
C14H20N2O8S3
Molecular Weight
440.51 g/mol
Parent drug
Dorzolamide
IUPAC Name
2-(Ethyl((4S, 6S)-6-methyl-7, 7-dioxido-2-sulfamoyl-5, 6-dihydro-4H-thieno[2, 3-b]thiopyran-4-yl)amino)succinic acid
Synonyms
N/A
References
“Dorzolamide Ophthalmic: MedlinePlus Drug Information.” Medlineplus.gov, 2018, medlineplus.gov/druginfo/meds/a697049.html#:~:text=Ophthalmicdorzolamideisusedto, thepressureintheeye..
Status
In-stock
